Study Shows How Vaping Can Damage Your Airway

New Cleveland Clinic research shows how e-cigarettes and vaping can damage your airway and also put you at risk for viral infections.

Translate to Spanish or other 102 languages!

According to researchers, the popular devices have been shown to damage cells that protect your airway. Image for illustration purposes
According to researchers, the popular devices have been shown to damage cells that protect your airway. Image for illustration purposes
- Advertisement -

CLEVELAND CLINIC – A Cleveland Clinic study is highlighting the dangers of e-cigarettes and vaping. 

According to researchers, the popular devices have been shown to damage cells that protect your airway. 
 
“Why is this important? Because if the integrity of the airway barrier is disrupted, everything can get in, viruses can get in, or other pollutions or allergens can get in,” explained Fariba Rezaee, MD, pediatric pulmonologist for Cleveland Clinic Children’s.   
 
Dr. Rezaee said they created a breathing simulator for the study, and then tested different devices and flavors to see how they would impact cells in the airway. 

She said they discovered that no matter the device, or flavors introduced, they all caused harm. 

- Advertisement -

However, the combination of flavor and nicotine were said to be the worst.  

They also learned that the use of e-cigarettes or vapes can put a person at greater risk for viral infections, like RSV.
 
“We exposed the cells to the aerosols generated by this machine, and then we did the viral infection, and we saw that the effect was worse,” she noted. “So basically we saw more viral infections and more damage to the airway epithelial cells.”  
 
Dr. Rezaee said more research needs to be done on the long-term effects. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.

HHS Opens $1 Million Funding Opportunity to Strengthen Women’s Preventive Care

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a Notice of Funding Opportunity (NOFO) for the Women’s Initiative for Screening and Health (WISH) program.

Coordinated Care Supports Mother through Cancer and Pregnancy

Mega Doctor News By Kristen Zapata | UT Health San Antonio Two pink...
- Advertisement -